Co-Chair: Kelly Brownell (formerly, Director, Director Yale Rudd Center for Food Policy & Obesity, now Dean of the School of Public Policy at Duke University). Keynote speakers included Jeffrey Friedman of Rockefeller University, credited as a co-discoverer of the hormone which is critical to energy balance, and weight control – leptin. The roster of speakers included a broad array of thought-leaders with interests in obesity from the standpoint of public policy and public health, along with domain experts in the science behind the addictive aspects of food through to the consequences of obesity such as cancer, cardiovascular, and metabolic disease. The playwright, Laura Jaqmin focused on weight and body image in her new play, January Joiner, which was able to bring the subject to life.
SCHEDULE OF EVENTS
Thursday, January 24, 2013 – The Study at Yale, New Haven (1157 Chapel Street)
5:00-6:00 COCKTAIL RECEPTION
6:00-6:30 OVERVIEW OF OBESITY
Kelly D. Brownell, Director, Yale Rudd Center for Food Policy & Obesity (Event Co-Chair)
6:30-6:45 SCENE: FAT PIG, by Neil Labute
6:45-7:30 FINANCING INNOVATION
David Scheer (Moderator) President, Scheer & Company (Event Chair)
Kurt Graves, Chairman, President & CEO; Intarcia Therapeutics
Roger Hill, Executive Director, Business Development & Licensing; Boehringer-Ingelheim Pharmaceuticals, Inc.
Lorence Kim, Managing Director, Goldman & Sachs & Company
James Boylan, Senior Managing Director, Head of Investment Banking; Leerink Swann LLC
Jessica Chutter, Managing Director, Chairman of Biotechnology Investment Banking; Morgan Stanley
Nicholas Galakatos, Co-Founder & Managing Director, Clarus Ventures
David Wurzer, Senior Managing Director, Investments; Connecticut Innovations
Kelly Murphy, Deputy Mayor for Economic Development, City of New Haven; Interim CEO, Economic Development Corporation of New Haven
~~~~~~~~~~~~~~
Friday, January 25, 2013 – Long Wharf Theatre Mainstage, New Haven (222 Sargent Drive)
8:30-9:00 REGISTRATION
9:00-9:30 OPENING REMARKS
David Scheer, President, Scheer & Company (Event Chair)
Peter Salovey, Provost, Chris Argyris Professor of Psychology, President-Elect; Yale University
Gordon Edelstein, Artistic Director, Long Wharf Theatre
9:30-9:45 SCENE: BREAKFAST, LUNCH AND DINNER, by Luis Alfaro
PUBLIC & GLOBAL HEALTH PERSPECTIVES
9:45-9:55 OBESITY: A PUBLIC HEALTH OVERVIEW
Kelly D. Brownell, Director, Yale Rudd Center for Food Policy & Obesity (Event Co-Chair)
9:55-10:05 OBESITY & CHRONIC DISEASE: NATIONAL & GLOBAL PUBLIC HEALTH PERSPECTIVE
Susan T. Mayne, Chair, Department of Chronic Disease Epidemiology; Yale School of Public Health
10:05-10:15 TBD
Felicia Knaul, Director, Harvard Global Equity Initiative
10:15-10:25 INITIATIVES FOR PREVENTION
Margaret Grey, Dean, Annie Goodrich Professor; Yale School of Nursing
10:25-10:40 EXHIBITING HEALTH: MUSEUMS AS A VENUE FOR PUBLIC HEALTH INTERVENTION
Jeannette R. Ickovics, Professor of Epidemiology & Psychology, Yale School of Public Health
10:40-11:10 OKLAHOMA CITY: A CASE STUDY
The Honorable Mick Cornett Mayor, Oklahoma City, OK
11:10-11:20 A LEGISLATOR’S PERSPECTIVE
The Honorable Rosa DeLauro, U.S. House of Representatives, Connecticut 3rd Congressional District
GENETICS, GENOMICS & PATHOPHYSIOLOGY
11:20-11:30 GENETICS: AN OVERVIEW
Richard P. Lifton, Chair, Department of Genetics; Yale School of Medicine
11:30-12:00 VANGUARD AWARD LECTURE: THE LEPTIN STORY
Jeffrey M. Friedman, Investigator, Howard Hughes Medical Institute; The Rockefeller University
12:00-12:45 Lunch
OBESITY & THE BRAIN
12:45-12:55 OBESITY & THE BRAIN: AN OVERVIEW
John H. Krystal, Chair, Department of Psychiatry; Yale School of Medicine
12:55-1:05 BIOLOGY & PATHOPHYSIOLOGY OF OBESITY
Tamas L. Horvath, Chair, Section of Comparative Medicine; Yale School of Medicine
1:05-1:15 NEURAL CIRCUITS WHICH DRIVE OBESITY & MODELS FOR TRANSLATIONAL RESEARCH
Ralph DiLeone, Associate Professor of Psychiatry & Neurobiology, Yale School of Medicine
1:15-1:25 MIND vs. METABOLISM
Dana Small, Associate Fellow, John Pierce Laboratory; Associate Professor of Psychiatry; Yale School of Medicine
1:25-1:35 STRESS-INDUCED EATING
Rajita Sinha, Professor of Psychiatry; Director, Yale Interdisciplinary Stress Center; Yale School of Medicine
1:35-1:45 SCENE: THE WHALE, by Sam Hunter
COMPLICATIONS & CONSEQUENCES
1:45-2:15 KEYNOTE: CARDIOVASCULAR COMPLICATIONS
Antonio M. Gotto, Jr., Dean Emeritus, Co-Chairman of the Board of Overseers; Weill Cornell Medical College
2:15-2:25 DIABETES AS A MAJOR COMPLICATION OF OBESITY Robert Sherwin, Section Chief, Endocrinology; Yale School of Medicine
2:25-2:35 OBESITY, METABOLIC SYNDROME & THE LIVER
Gerald I. Shulman, Professor of Endocrinology & Cellular & Molecular Physiology, Yale School of Medicine
2:35-2:45 PEDIATRIC ENDOCRINOLOGY
Sonia Caprio, Professor of Pediatric Endocrinology, Yale School of Medicine
2:45-2:55 OBESITY & THE RISK OF CANCER
Susan T. Mayne, Chair, Department of Chronic Disease Epidemiology; Yale School of Public Health
A SPECIAL DISCUSSION ABOUT A RARE DISEASE
2:55-3:05 INTRODUCTION & CONTEXT
Jerome B. Zeldis, Chief Medical Officer, Celgene Corporation; CEO, Celgene Global Health
3:05-3:15 DYSLIPIDEMIAS & RETT SYNDROME
Monica J. Justice, Professor, Department of Molecular & Human Genetics; Baylor College of Medicine
APPROACHES TO THERAPY
3:25-4:00 PANEL DISCUSSION: SURGICAL APPROACHES TO THERAPY
Robert L. Bell (Moderator) Associate Professor of Surgery, Yale School of Medicine; Director, Yale Bariatric Surgery Program
P
aul Hermes, Chief Technology Officer; Vice President, Research & Development; Covidien Surgical Solutions
Kurt Azarbarzin, CEO & Founder, SurgiQuest, Inc.
Jerry Liebrand, Advisor, OmniGuide; President, Liebrand Consulting, LLC
4:00-4:45 PANEL DISCUSSION: PHARMACEUTICAL APPROACHES TO THERAPY
David Scheer (Moderator) President, Scheer & Company
Tim Rolph, Chief Scientific Officer, Cardiovascular & Metabolic Diseases Research Unit; Pfizer, Inc.
Peter P. Stein, Vice President, Diabetes Disease Area Leader, Cardiovascular & Metabolism; Janssen Research & Development, LLC
Marc Laruelle, Vice President & Neurosciences Therapeutic Area Head, New Medicines; UCB Pharma, S.A.
Simeon Taylor, Vice President, Research & Scientific Affairs; Bristol-Myers Squibb
ROLE OF THE PAYER & WELLNESS INITIATIVES
4:50-5:00 THE HEALTH PLAN AS A KEY PARTNER IN COMBATING OBESITY
Samuel R. Nussbaum, Executive Vice President, Clinical Health Policy; Chief Medical Officer; Wellpoint, Inc.
5:00-5:10 ROLE OF THE PAYER & WELLNESS INITIATIVES
Paul Coppola, Head of Wellness Program Strategy & Development, Aetna, Inc.
5:10-5:20 ROLE OF INITIATIVES IN PARTNERING & PATIENT ADVOCACY
Eric Racine, Vice President, Partners in Patient Health; Sanofi
5:20-5:30 QUESTION & ANSWER SESSION
INNOVATION
5:30-6:00 PANEL DISCUSSION: INNOVATION & THE INTERPLAY OF SCIENCE, TECHNOLOGY, CLINICAL & REGULATORY AFFAIRS
Richard E. Kuntz (Moderator) Senior Vice President, Chief Scientific & Regulatory Officer; Medtronic, Inc.
Thomas E. Hughes, President & CEO, Zafgen, Inc.
John LaMattina, Senior Partner, PureTech Ventures
Lou Tartaglia, President & CEO, Ember Therapeutics
Timothy A. Riley, Senior Vice President, Technology Assessment & Quality Assurance; Nektar Therapeutics
Andy Levine, Chief Technology Officer, GI Dynamics
Jean-Paul Castaigne, President & CEO, Angiochem
6:00-7:45 Dinner
8:00-10:00 Performance of JANUARY JOINER: A WEIGHT LOSS HORROR COMEDY
10:00-10:45 Post-Performance Discussion
David Scheer, President, Scheer & Company
Eric Ting, Associate Artistic Director, Long Wharf Theatre; Director, JANUARY JOINER
Laura Jacqmin, Playwright, JANUARY JOINER
Jeannette Ickovics, Professor of Epidemiology & Psychology, Yale School of Public Health